CEBPA, CCAAT enhancer binding protein alpha, 1050

N. diseases: 201; N. variants: 21
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 Biomarker disease BEFREE Our data indicate that a link between CEBPA and the genes of the minimally deleted region, among them HNRNPK contributes to leukemogenesis in acute myeloid leukemia with del(9q). 30476680 2019
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 Biomarker disease BEFREE These results indicate that MLF1 is a positive regulator that is critical for C/EBPα stability in the early phases of hematopoiesis and leukemogenesis. 29296815 2017
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 AlteredExpression disease BEFREE These results indicate that COP1 and Trib1 act as an oncoprotein complex functioning upstream of C/EBPα, and its ligase activity is crucial for leukemogenesis. 23884858 2013
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 AlteredExpression disease BEFREE Therefore, we postulate that the inability of C/EBPα and GATA-1 to down-regulate DACH1 expression induced by MLL-AF9 during myeloid differentiation may contribute to t(9;11) leukemogenesis. 22902925 2012
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 PosttranslationalModification disease BEFREE In this review we will discuss and summarize briefly our current knowledge of epigenetic alterations in leukemias and will turn our attention to a concrete example of epigenetic deregulation of CCAAT/enhancer-binding protein alpha (C/EBPα), a key regulator for granulocytic differentiation of common myeloid progenitor cells in order to highlight the cooperativity of genetic and epigenetic mechanisms acting on this gene during the process of leukemogenesis. 21601364 2011
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 AlteredExpression disease BEFREE Our previous data indicated that Trib2-mediated degradation of the transcription factor, CCAAT/enhancer-binding protein-alpha (C/EBPalpha), is important for leukemogenesis. 20410507 2010
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 GeneticVariation disease BEFREE The gene and miRNA expression profiling provided insights into leukemogenesis of the CN-AML molecular high-risk group, indicating that CEBPA mutations are associated with partial erythroid differentiation. 18809607 2008
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 Biomarker disease BEFREE These data indicate that CEBPA may exhibit oncogenic as well as tumor suppressor properties in human leukemogenesis. 16873674 2006
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.090 Biomarker disease BEFREE Mutation of the CEBPA may play an important role in leukemogenesis and prognosis. 15746035 2005